Eli Lilly CEO David Ricks pushed back on Anthropic CEO Dario Amodei’s optimistic claims that AI will rapidly transform medicine and cure most diseases, calling them ludicrous. Ricks argued that drug discovery and development remain far more complex than such aggressive AI timelines suggest.